Abbott warned on Thursday it expects more than $1 billion in financial headwinds this year from a sharp decline in COVID-19 testing demand, new U.S. tariffs, and the government's foreign aid freeze.

ABBOTT warned on Thursday it expects more than $1 billion in financial headwinds this year from a sharp decline in Covid-19 testing demand, new US tariffs and the government’s foreign aid freeze.

Abbott Laboratories (ABT) reports robust earnings growth and margin expansion, driven by medical devices, despite headwinds ...

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

The global diagnostic imaging services market size was US$ 811.20 million in 2021. The global diagnostic imaging services market is expected to grow to US$ 1161.1 million by 2030 by registering a ...

The Motley Fool. DATE Thursday, July 17, 2025 at 9 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer — Robert ...

Q2 2025 Earnings Call Transcript July 17, 2025 Abbott Laboratories reports earnings inline with expectations. Reported EPS is ...

The global flame retardants market was US$ 6.1 billion in 2021. The global flame retardants market is expected to grow to US$ 10.1 billion by 2030 by registering a compound annual growth rate (CAGR) ...

China has reported that its economy slowed in the last quarter as President Donald Trump's trade war escalated, but it still ...

Synchron rarely lets journalists visit its New York office. What I saw there reveals the growing potential of brain-computer ...